HomeCompareCBIXF vs QSR

CBIXF vs QSR: Dividend Comparison 2026

CBIXF yields 18.60% · QSR yields 3.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBIXF wins by $42.3K in total portfolio value
10 years
CBIXF
CBIXF
● Live price
18.60%
Share price
$10.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$67.0K
Annual income
$5,789.69
Full CBIXF calculator →
QSR
QSR
● Live price
3.40%
Share price
$73.90
Annual div
$2.51
5Y div CAGR
-0.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$386.99
Full QSR calculator →

Portfolio growth — CBIXF vs QSR

📍 CBIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBIXFQSR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBIXF + QSR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBIXF pays
QSR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBIXF
Annual income on $10K today (after 15% tax)
$1,581.40/yr
After 10yr DRIP, annual income (after tax)
$4,921.24/yr
QSR
Annual income on $10K today (after 15% tax)
$288.70/yr
After 10yr DRIP, annual income (after tax)
$328.94/yr
At 15% tax rate, CBIXF beats the other by $4,592.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBIXF + QSR for your $10,000?

CBIXF: 50%QSR: 50%
100% QSR50/50100% CBIXF
Portfolio after 10yr
$45.8K
Annual income
$3,088.34/yr
Blended yield
6.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QSR right now

CBIXF
No analyst data
QSR
Analyst Ratings
27
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$81.57
+10.4% upside vs current
Range: $71.00 — $90.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBIXF buys
0
QSR buys
0
No recent congressional trades found for CBIXF or QSR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBIXFQSR
Forward yield18.60%3.40%
Annual dividend / share$2.00$2.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.8%
Portfolio after 10y$67.0K$24.7K
Annual income after 10y$5,789.69$386.99
Total dividends collected$36.7K$3.7K
Payment frequencyquarterlyquarterly
SectorStockStock

Year-by-year: CBIXF vs QSR ($10,000, DRIP)

YearCBIXF PortfolioCBIXF Income/yrQSR PortfolioQSR Income/yrGap
1← crossover$12,560$1,860.47$11,037$336.93+$1.5KCBIXF
2$15,624$2,183.95$12,154$344.76+$3.5KCBIXF
3$19,256$2,538.85$13,357$351.99+$5.9KCBIXF
4$23,529$2,924.42$14,651$358.62+$8.9KCBIXF
5$28,515$3,339.49$16,041$364.68+$12.5KCBIXF
6$34,294$3,782.47$17,534$370.18+$16.8KCBIXF
7$40,945$4,251.39$19,136$375.14+$21.8KCBIXF
8$48,556$4,743.96$20,856$379.58+$27.7KCBIXF
9$57,212$5,257.64$22,699$383.52+$34.5KCBIXF
10$67,007$5,789.69$24,675$386.99+$42.3KCBIXF

CBIXF vs QSR: Complete Analysis 2026

CBIXFStock

Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases to use in the study of kinase-molecule interactions. The company also offers profiling, NanoBRET TE intracellular kinase cell-based assay, protein detection and interaction, live-cell kinase assay, ClariCELL kinase cell-based assay, crystallization, weak affinity chromatography, and tyrosine kinase cell-based assay services, as well as custom production of ultra-pure proteins for crystallography. It also focuses on developing products for the treatment of various diseases, such as AS-0141, an orally bioavailable small molecule inhibitor of CDC7 kinase that is in preclinical trials to treat cancer; AS-0871, a small molecule drug for inflammatory and immune disorders, which is in Phase 1 clinical trials; and AS-1763, an orally bioavailable and non-covalent inhibitor for the treatment of chronic lymphocytic leukemia and other B cell malignancies that is in preclinical trials. The company has collaborations with Johnson & Johnson, Sierra Oncology, Sumitomo Dainippon Pharma, Gilead Sciences, and BioNova Pharmaceuticals. Carna Biosciences, Inc. was founded in 2003 and is based in Kobe, Japan.

Full CBIXF Calculator →

QSRStock

Restaurant Brands International Inc. operates as quick service restaurant company in Canada and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and others. It is also involved in owning and franchising BK, a fast food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, french fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS restaurants quick service restaurants that offer subs, soft drinks, and local specialties. As of February 15, 2022, the company had approximately 29,000 restaurants in 100 countries under the Tim Hortons, Burger King, Popeyes, And Firehouse Subs brands. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Full QSR Calculator →
📬

Get this CBIXF vs QSR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBIXF vs SCHDCBIXF vs JEPICBIXF vs OCBIXF vs KOCBIXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.